Unidade de investigación
Servicio
Complexo Hospitalario Universitario de Vigo
Vigo, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (31)
2024
-
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11)
Gastroenterologia y Hepatologia
-
Clinical usefulness of serum angiotensin converting enzyme in silicosis
Pulmonology, Vol. 30, Núm. 4, pp. 370-377
-
Dispersal history of SARS-CoV-2 in Galicia, Spain
Journal of Medical Virology, Vol. 96, Núm. 7
-
Influence of social support and stressful life events on adherence to colorectal cancer screening using faecal occult blood test in Spanish medium risk population
Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 14-23
2023
-
Inadequate social support decreases survival in decompensated liver cirrhosis patients
Gastroenterologia y Hepatologia, Vol. 46, Núm. 1, pp. 28-38
-
Perceived barriers and benefits in the participation in faecal occult blood test colorectal cancer screening programme
Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 185-194
2022
-
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331
-
Decline of Tuberculosis Rates and COVID-19 Pandemic. Fact or Fiction?
Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 272-274
-
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control
The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049
-
Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients
International Journal of Geriatric Psychiatry, Vol. 37, Núm. 6
-
Rawl's questionnaire spanish validation for colorectal cancer screening with faecal occult blood testing
Gastroenterologia y Hepatologia, Vol. 45, Núm. 2, pp. 106-113
-
Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study
Neurological Sciences, Vol. 43, Núm. 4, pp. 2537-2544
-
Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1529-1550
2021
-
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073
-
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Advances in Therapy, Vol. 38, Núm. 10, pp. 5398-5411
-
Predictors of clinically significant quality of life impairment in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1
-
Prevalence and Clinical Impact of Systemic Autoimmune Rheumatic Disease in Patients with Silicosis
Archivos de Bronconeumologia, Vol. 57, Núm. 9, pp. 571-576
-
Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques
Frontiers in Medicine, Vol. 8
-
Serum levels of inflammatory mediators as prognostic biomarker in silica exposed workers
Scientific reports, Vol. 11, Núm. 1, pp. 13348
2020
-
Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36
Neuron, Vol. 107, Núm. 2, pp. 292-305.e6